1-Prop-2-ynyl-1H-benzimidazol-2-amine

Acta Crystallographica Section E: Structure Reports Online

Volumn 67, Issue 12, 2011, Pages

  Agarwal, Alka ^a   Singh, Manavendra K ^a   Awasthi, Satish K ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

data to parameter ratio = 25.2; mean (C C) = 0.002 ; R factor = 0.054; single crystal X ray study; T = 293 K; wR factor = 0.137

Indexed keywords

EID: 83155178517     PISSN: None     EISSN: 16005368     Source Type: Journal    
DOI: 10.1107/S1600536811042772     Document Type: Article

References (20)

1. Agarwal, A., Singh, M. K., Singh, S., Bhattacharya, S. & Awasthi, S. K. (2011). Acta Cryst. E67, o2637-o2638.
2. Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Sommen, C., Lacrampe, J., Janssens, F. & Wyde, P. R. (2003). Antiviral. Res. 60, 209-219.
3. Cuberens, M. & Contijoch, M. R. (1997). Chem. Pharm. Bull. 45, 1287-1292.
4. Del Poenta, M., Bixel, A. S., Barchiesi, F., Tidwell, R. R., Boykin, D., Scalise, G. & Perfect, J. R. (1999). J. Antimicrob. Chemother. 44, 223-228.
5. Dios, A. de, et al. (2005). J. Med. Chem. 48, 2270-2273.
6. Garuti, L. & Roberti, M. (2002). Bioorg. Med. Chem. Lett. 12, 2707-2710.
7. Garuti, L., Varoli, L., Cermelli, C., Baggio, G., Lupo, L., Malagoli, M. & Castelli, M. (1998). Anti-Cancer Drug Des. 13, 969-980.
8. Lilienkampf, A., Mao, J., Wan, B., Wang, Y., Franzblau, S. G. & Kozikowski, A. P. (2009). J. Med. Chem. 52, 2109-2118.
9. Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M. & van de Streek, J. (2006). J. Appl. Cryst. 39, 453-457.
10. Mor, M., Bordi, F., Silva, C., Rivara, S., Zuliana, V., Vacondio, F., Rivara, M., Barocelli, E., Bertoni, S., Ballabeni, V., Magnanini, F., Impicciatore, M. & Plazzi, P. V. (2004). Bioorg. Med. Chem. 12, 663-674.
11. Nawrocka, W., Sztuba, B., Liszkiewicz, H., Kowalska, M. W., Wietrzyk, J., Nevozhai, D. & Opolski, A. (2005). Pol. J. Chem. 79, 709-716.
12. Nawrocka, W., Zimecki, M., Kuznicki, T. & Kowalska, M. W. (1999). Arch. Pharm. 332, 85-90.
13. Nofal, Z. M., Fahmy, H. H. & Mohamed, H. S. (2002). Arch. Pharm. Res. 25, 250-257.
14. Omar, M. T., Fahmy, H. H. & Mohamed, H. S. (1996). Egypt. J. Pharm. Sci. 37, 606-620.
15. Oxford Diffraction (2009). CrysAlis PRO. Oxford Diffraction Ltd, Yarnton, Oxfordshire, England.
16. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
17. Singh, M. K., Agarwal, A. & Awasthi, S. K. (2011). Acta Cryst. E67, o1137.
18. Singh, M. K., Agarwal, A., Mahawar, C. & Awasthi, S. K. (2011). Acta Cryst. E67, o1382.
19. Singh, S., Singh, M. K., Agarwal, A., Hussain, F. & Awasthi, S. K. (2011). Acta Cryst. E67, o1616-o1617.
20. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.